$0.97
▲ +1.3% Today
as of Oct 22, 16:53 ET
Last 30 days
Recent Press Releases & News
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
XRTX earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±16.9% on average; after the most recent report on May 15, 2026 it moved +28.9%. The share price of $0.97 sits near its 52-week low.
Overview
52-week range
$0.90
$3.89
2% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+12.0%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.58 | — | — | -205.3% | +28.9% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-0.13 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.19 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.19 | — | — | — | -4.9% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for XRTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
XRTX earnings FAQ
How does XRTX stock usually react to earnings?
Across the last 2 reports the average next-day move was ±16.9%, up 1 times and down 1 times.